Search results
2024 NFL Draft cornerbacks rankings and analysis
NBC Sports via Yahoo Sports· 4 days agoWiggins was ready to assume CB1 shutdown corner this year, and did so in impressive fashion. His 44% completion rate with a 44.4 NFL passer rating in...
No Religion? At These Faith-Based Retirement Communities, No Problem.
New York Times· 1 hour agoBefore Helen Leddy moved to Shell Point Retirement Community in Fort Myers, Fla., last year, she got...
29 Problem-Solving Walmart Products For Those Issues You Didn’t Even Know Had Legit Solutions
BuzzFeed via Yahoo News· 5 days ago—Heidi Price: $3.98 Target 5.A Neutrogena SPF 50 sunscreen stick that's TSA-friendly, spill-proof,...
‘Erosion has made my house worthless, but I’m happy to die here’
The Telegraph via Yahoo News· 5 days agoBut there is no such obligation to say about coastal erosion and sea level rises,” explains Angela...
World Snooker Championship 2024 results: Jak Jones beats Zhang Anda, Mark Selby trails Joe O'Connor
BBC News· 7 days agoFour-time world champion Mark Selby is in danger of a shock first-round exit as he trails Crucible...
NFL Draft 2024: Best remaining players after Round 1
SB Nation· 2 days agoCooper DeJean, Kool-Aid McKinstry, and Johnny Newton highlight the players still available ahead of Round 2
Farm suicides, anger mount in Indian villages that Modi promised hope
Al Jazeera· 2 days agoLike everyone else around him, Vithal Rathod was excited for what the future held for him and their...
May Brings More Than Flowers: Art Fairs to See in New York
New York Times· 3 days agoBeyond Frieze, the options for collectors include events devoted to contemporary African art as well...
Middle-income Americans feel more optimism about finances and economy's direction: survey
FOX Business· 4 days agoAlthough inflation is still a top concern, middle-income Americans said they've gotten used to...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoPhase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback HB-200 accepted for oral abstract presentation
